Advertisement

Topics

Search Results for "Recall Promus Heart Stent"

09:14 EDT 29th March 2017 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Failure HF

Heart Transplantation

Matching News

Medtronic announces recall of some Endurant, Endurant II stent grafts

A recall was initiated by Medtronic involving 3,331 units of its 23- and 25-mm Endurant and Endurant II stent graft systems m -More- 

Higher heart risk seen with Abbott dissolving stent after two years: study

WASHINGTON (Reuters) - Patients who received Abbott Laboratories' novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company's ...

New self-expanding heart stent from Biotronik proves effective in clinical trial

A new metallic heart

Japan OKs bioresorbable heart stent from Abbott

The Japanese Ministry of Health, Labor and Welfare has given Abbott approval for its Absorb bioresorbable heart stent for use -More- 

Higher heart risk seen with Abbott dissolving stent after 2 years -study – Daily Mail

Higher heart risk seen with Abbott dissolving stent after 2 years -studyDaily MailWASHINGTON, March 18 (Reuters) - Patients who received Abbott Laboratories' novel dissolving vascular stent had a sign...

BRIEF-Abbott says Japan approves its absorbable heart stent

* Abbott laboratories - japan has approved company's absorb bioresorbable heart stent Source text for Eikon: Further company coverage:

Boston Scientific announces recall of Lotus heart devices

A recall was initiated by Boston Scientific involving all of its Lotus Valve heart devices in Europe and in US clinical trial -More- 

Japan approves use of Abbott’s bioresorbable heart stent

Abbott Laboratories’ new Absorb bio

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement